In univariate competing risk regression models considering (further) decompensation as the outcome of interest and HCC development, liver transplantation and non-liver-related mortality as competing risks (liver transplantation was always preceded by further decompensation or HCC development), LSM values, (a history of or current) ascites and MELD score (all p < 0.001) as well as serum albumin levels (p = 0.002) had strong prognostic implications, while PLT count was of no prognostic value in this context (p = 0.140), as shown in Table S2. The gene discussed is ALB; the disease is hepatocellular carcinoma.